Carroll Patrick Harrison 4

What Happened

• Patrick Harrison, Chief Medical Officer and director of Hims & Hers Health, Inc. (HIMS), received a grant of 150,489 restricted stock units (RSUs) reported on Mar 11, 2026. The transaction is reported as an award/acquisition at $0.00 (derivative), meaning no cash was paid; each RSU represents a contingent right to one share of Class A common stock.

Key Details

• Transaction date: March 11, 2026; Form 4 filed March 13, 2026 (within the standard two-business-day reporting window).
• Grant size and price: 150,489 RSUs at $0.00 (derivative award); reported value $0 on grant date.
• Shares owned after transaction: Not reported in the provided excerpt.
• Footnote F1: Each RSU converts to one share of Class A common stock upon vesting.
• Footnote F2: RSUs vest based on service over 4 years in substantially equal quarterly installments on Mar 15, Jun 15, Sep 15, and Dec 15, with the first vesting date on June 15, 2026.
• No 10b5-1 plan, tax-withholding sale, or cash exercise indicated.

Context

• This is an equity compensation award (RSUs), not a market purchase or sale; such grants are common for executives and are compensation/retention tools rather than direct bullish or bearish signals. The RSUs are contingent on continued service and will convert to shares only as they vest.